RedHill Biopharma Ltd.RDHLNASDAQ
Loading
Book Value/Share Growth TrendStable
Percentile Rank69
Year-over-Year Change
Year-over-year book value per share growth
Latest
0.00%
↑ 100% vs avg
Percentile
P69
Within normal range
Streak
1 qtr
Consecutive growthStable
Average
-190.67%
Historical baseline
| Period | Value |
|---|---|
| Q2 2025 | 0.00% |
| Q1 2025 | -34.66% |
| Q4 2024 | 0.00% |
| Q3 2024 | -7107.04% |
| Q2 2024 | 0.00% |
| Q1 2024 | -99.02% |
| Q4 2023 | -29.81% |
| Q3 2023 | -65.71% |
| Q2 2023 | 6.99% |
| Q1 2023 | 103.96% |
| Q4 2022 | 27.97% |
| Q3 2022 | -243.18% |
| Q2 2022 | -111.12% |
| Q1 2022 | -155.98% |
| Q4 2021 | -27.97% |
| Q3 2021 | -61.05% |
| Q2 2021 | -48.67% |
| Q1 2021 | 241.95% |
| Q4 2020 | -53.16% |
| Q3 2020 | -20.28% |
| Q2 2020 | -21.86% |
| Q1 2020 | -27.26% |
| Q4 2019 | 111.20% |
| Q3 2019 | -28.38% |
| Q2 2019 | -23.81% |
| Q1 2019 | -18.19% |
| Q4 2018 | 6.41% |
| Q3 2018 | 39.71% |
| Q2 2018 | -28.70% |
| Q1 2018 | -21.33% |
| Q4 2017 | 9.38% |
| Q3 2017 | -30.42% |
| Q2 2017 | -17.96% |
| Q1 2017 | -23.08% |
| Q4 2016 | 41.87% |
| Q3 2016 | -17.43% |
| Q2 2016 | -10.99% |
| Q1 2016 | -10.30% |
| Q4 2015 | -36.12% |
| Q3 2015 | 157.27% |